AVATAR-AF
Trial Details
- Trial statusCompleted
- Study email contactavatar@imperial.ac.uk
- Chief InvestigatorDr Prapa Kanagaratnam
- Project managerDr Thiagarajah Sasikaran
- SponsorImperial College London
- Phase3
- View clinicaltrials.gov website
- View Trial Locations
Ablation Verses Anti-arrhythmic Therapy for Reducing All Hospital Episodes from Recurrent Atrial Fibrillation
Design and Objective
A multi centre, randomised trial to determine if antral AF ablation without electrophysiological confirmation of PV isolation is more effective than anti-arrhythmic agents at achieving freedom from hospital based treatment.
Key inclusion criteria
1. Documented paroxysmal atrial fibrillation 2. Modification or initiation of anti-arrhythmic agent required for symptom control 3. Males or females eighteen (18) to eighty (80) years of age. 4. Suitable candidate for catheter ablation 5. Signed informed consent